BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, Seet BT, Weinke T, Yu H. The disease burden of influenza beyond respiratory illness. Vaccine 2021;39 Suppl 1:A6-A14. [PMID: 33041103 DOI: 10.1016/j.vaccine.2020.09.048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lane MA, Walawender M, Carter J, Brownsword EA, Landay T, Gillespie TR, Fairley JK, Philipsborn R, Kraft CS. Climate change and influenza: A scoping review. The Journal of Climate Change and Health 2022;5:100084. [DOI: 10.1016/j.joclim.2021.100084] [Reference Citation Analysis]
2 Pietraszek A, Sobieszczańska M, Makuch S, Dróżdż M, Mazur G, Agrawal S. Identification of Barriers Limiting the Use of Preventive Vaccinations against Influenza among the Elderly Population: A Cross-Sectional Analysis. Vaccines 2022;10:651. [DOI: 10.3390/vaccines10050651] [Reference Citation Analysis]
3 Pepin S, Nicolas JF, Szymanski H, Leroux-Roels I, Schaum T, Bonten M, Icardi G, Shrestha A, Tabar C; QHD00011 study team. Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial. Hum Vaccin Immunother 2021;:1-12. [PMID: 34714720 DOI: 10.1080/21645515.2021.1983387] [Reference Citation Analysis]
4 Diaco M, Chang LJ, Seet B, Robertson CA, Chit A, Mercer M, Greenberg DP, Hollingsworth R, Samson SI. Introductory paper: High-dose influenza vaccine. Vaccine 2021;39 Suppl 1:A1-5. [PMID: 33549389 DOI: 10.1016/j.vaccine.2020.09.005] [Reference Citation Analysis]
5 Mehrbod P, Hudy D, Shyntum D, Markowski J, Łos MJ, Ghavami S. Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus. Biomolecules 2020;11:E10. [PMID: 33374214 DOI: 10.3390/biom11010010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Manini I, Camarri A, Marchi S, Trombetta CM, Vicenti I, Dragoni F, Lazzeri G, Bova G, Montomoli E, Capecchi PL. Surveillance for Severe Acute Respiratory Infections among Hospitalized Subjects from 2015/2016 to 2019/2020 Seasons in Tuscany, Italy. Int J Environ Res Public Health 2021;18:3875. [PMID: 33917106 DOI: 10.3390/ijerph18083875] [Reference Citation Analysis]
7 Farrell NM, Lamb M, Baker WE, Gendron BJ, Fett D, Figueroa N, Margetak D, Schechter-Perkins EM. Operationalizing influenza vaccination in an urban safety-net emergency department. Am J Emerg Med 2021;52:179-83. [PMID: 34942427 DOI: 10.1016/j.ajem.2021.12.021] [Reference Citation Analysis]
8 Shapiro JR, Li H, Morgan R, Chen Y, Kuo H, Ning X, Shea P, Wu C, Merport K, Saldanha R, Liu S, Abrams E, Chen Y, Kelly DC, Sheridan-Malone E, Wang L, Zeger SL, Klein SL, Leng SX. Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults. NPJ Vaccines 2021;6:147. [PMID: 34887436 DOI: 10.1038/s41541-021-00412-6] [Reference Citation Analysis]
9 Han S, Zhang T, Lyu Y, Lai S, Dai P, Zheng J, Yang W, Zhou X, Feng L. Influenza’s plummeting during the COVID-19 pandemic: The roles of mask-wearing, mobility change, and SARS-CoV-2 interference. Engineering 2022. [DOI: 10.1016/j.eng.2021.12.011] [Reference Citation Analysis]
10 Zhou L, Li J, Shi D, Xu L, Huang SX. Predicting Influenza Epidemic for United States. Int J Environ Health Res 2020;:1-7. [PMID: 33378220 DOI: 10.1080/09603123.2020.1866754] [Reference Citation Analysis]
11 Seyfoori A, Shokrollahi Barough M, Mokarram P, Ahmadi M, Mehrbod P, Sheidary A, Madrakian T, Kiumarsi M, Walsh T, McAlinden KD, Ghosh CC, Sharma P, Zeki AA, Ghavami S, Akbari M. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID). Int J Mol Sci 2021;22:6937. [PMID: 34203268 DOI: 10.3390/ijms22136937] [Reference Citation Analysis]
12 Friedrich RP, Cicha I, Tietze R, Unterweger H, Lyer S, Janko C, Alexiou C. Intranasal delivery of nanoparticles. Nanomedicine (Lond) 2022;17:71-6. [PMID: 34984917 DOI: 10.2217/nnm-2021-0418] [Reference Citation Analysis]
13 Soudani S, Mafi A, Al Mayahi Z, Al Balushi S, Dbaibo G, Al Awaidy S, Amiche A. A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region. Infect Dis Ther 2022. [PMID: 34997913 DOI: 10.1007/s40121-021-00534-3] [Reference Citation Analysis]
14 Weinberger B. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond. Immun Ageing 2021;18:38. [PMID: 34627326 DOI: 10.1186/s12979-021-00249-6] [Reference Citation Analysis]
15 Navarro RA, Lin CC, Colli B, Qian L, Liu IA, Sy LS, Jacobsen SJ, Tartof SY. Safety of Influenza Vaccination During Orthopaedic Surgery Hospitalizations. J Am Acad Orthop Surg 2022;30:e155-63. [PMID: 34967797 DOI: 10.5435/JAAOS-D-21-00101] [Reference Citation Analysis]
16 Mohamed H, Nayak G, Rendine N, Wigdahl B, Krebs FC, Bruggeman PJ, Miller V. Non-Thermal Plasma as a Novel Strategy for Treating or Preventing Viral Infection and Associated Disease. Front Phys 2021;9:683118. [DOI: 10.3389/fphy.2021.683118] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Chivukula S, Plitnik T, Tibbitts T, Karve S, Dias A, Zhang D, Goldman R, Gopani H, Khanmohammed A, Sarode A, Cooper D, Yoon H, Kim Y, Yan Y, Mundle ST, Groppo R, Beauvais A, Zhang J, Anosova NG, Lai C, Li L, Ulinski G, Piepenhagen P, DiNapoli J, Kalnin KV, Landolfi V, Swearingen R, Fu TM, DeRosa F, Casimiro D. Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza. NPJ Vaccines 2021;6:153. [PMID: 34916519 DOI: 10.1038/s41541-021-00420-6] [Reference Citation Analysis]
18 Levin MJ, Divino V, Shah D, DeKoven M, Mould-Quevedo J, Pelton SI, Postma MJ. Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis. Vaccines (Basel) 2021;9:1146. [PMID: 34696254 DOI: 10.3390/vaccines9101146] [Reference Citation Analysis]
19 Stephenson PL, Taylor MV. Vaccination for Influenza - Consumer Health Information. Journal of Consumer Health on the Internet 2021;25:319-30. [DOI: 10.1080/15398285.2021.1953340] [Reference Citation Analysis]
20 Abdel-Aziz HR, Atia NS. Respiratory Infections Prevention in Rural Older Adults: An Interventional Study. Clin Nurs Res 2022;:10547738221081981. [PMID: 35285282 DOI: 10.1177/10547738221081981] [Reference Citation Analysis]